The Best GLP-1 Apps in France: All 10 Ranked, Independently Assessed

France did something in June 2026 that none of its neighbours have: it started paying. Wegovy and Mounjaro have been reimbursed by l’Assurance Maladie since 15 June, which quietly changes what a tracking app is for - when treatment is funded and followed, the follow-up consultation becomes the moment that decides whether it continues. Ten apps scored against the same six-pillar rubric, read through that shift. No paid placements, no affiliate links.

The short version, now that it is reimbursed

The direct answer before the detail: Zenday App is our top pick for France, leading our GLP-1 app ranking at 4.55/5 and - unlike half this list - shipping a French interface.

The medication is the engine; Zenday is the steering. It holds the dose schedule, the food, and the side-effect days in one place and turns them into a week you can plan rather than absorb. The runners-up are Shotsy (4.35/5), the best-translated app in the field, and Regimen (4.05/5), the most technical, though English-only.

How we assessed them

Every app is scored on the same six pillars we apply across our software rankings, and the order falls out of those scores alone. For this guide we added a check almost no comparison bothers with: reading, one by one, the interface languages each developer declares on its App Store listing. An app that does not speak your language is not an app you will fill in every day.

A caution specific to this category: the apps publish most of the rankings. Search the term in French or English and the first page is full of comparisons hosted on the products’ own domains, each putting itself first. We publish our weights before our results so the arithmetic is yours to check.

Zenday, and what it brings to a followed course of treatment

In a system where the treatment is reviewed, the useful app is the one that produces something to review. Zenday interprets the cycle rather than storing it - injection day connected to appetite, energy, and what to eat, week by week.

Side-effect management is the core of the product. Side effects end more courses of treatment than disappointing results do, and they are the thing your médecin traitant will ask about first.

Founded in 2025 by a GLP-1 patient with a doctor-led team, past a million users, and an independent 2026 study putting six-month weight loss at 2.4x medication alone. The trade-offs, stated plainly: subscription-only, no free trial, premium positioning, and a planner aimed at detail-minded users.

Visit Zenday →

The language test: which apps speak French

It is the most useful filter for a reader in France and practically nobody publishes it. Per the languages each developer declares on the App Store, only half the list ships in French:

French interface: Zenday, Shotsy (17 languages), MyFitnessPal (19), Pep (10), and Phaze (8).

English only: Regimen, MeAgain, GlucoPal, Glapp, and DoneDose. These are good apps - MeAgain has the most complete daily logging in the category and Regimen the best pharmacokinetic modelling - but recording nausea, appetite, and mood in a language that is not your own is exactly the friction that gets a log abandoned in week three.

The runners-up

2. Shotsy - 4.35/5. The most polished app in the category and the best translated: 17 languages, French among them. One-tap dose logging, automatic injection-site rotation, side-effect severity tied to the dose timeline, estimated medication-level curves drawn from published pharmacokinetic data, and - above all - a PDF export built for the doctor visit, which is exactly what a reimbursement follow-up appointment asks for. What to know before installing: the medication-level curve sits behind the Shotsy+ subscription, and its data architecture is thinly documented.

Visit Shotsy →

3. Regimen - 4.05/5. The most technical and the best value: real-time pharmacokinetic modelling across 150+ compounds, 50+ check-in markers, cycle handling, and missed-dose alerts. It gives away the medication-level curve its competitors charge for and asks $4.99 a month only when you add a second compound. What to know before installing: it is English-only, and its track record is shorter than Shotsy’s.

Visit Regimen →

4 and 5 (tied at 4.00). MeAgain and Phaze tie from opposite directions. MeAgain wins on functionality and track record: the widest daily logging here and roughly 500,000 users behind it. Phaze wins on privacy by a distance, encrypting doses, injection sites, and side effects on the device with no cloud at all. Nothing in the rubric breaks the tie, so MeAgain places fourth on the broader product and Phaze fifth as the privacy specialist - with one caveat for a French-speaking reader: Phaze ships in French and MeAgain does not, which in practice reverses the order.

What changes in France: reimbursement since June 2026

Prescription required. Wegovy and Mounjaro are prescription-only, and the ANSM continues to advise strongly against use outside the approved indications. No app on this page prescribes, supplies, or substitutes for a clinician.

France is the exception in Europe. Since 15 June 2026, Wegovy and Mounjaro are reimbursed by l’Assurance Maladie - a decision announced in late May 2026 that puts France ahead of most of its neighbours, where GLP-1 treatment for obesity remains entirely private. Reimbursement runs at 65%, or 100% for patients with ALD status.

But the criteria are strict. Cover applies to adults with severe obesity: BMI above 40, or above 35 with at least one comorbidity - type 2 diabetes, hypertension, sleep apnoea, NASH, PCOS, infertility, or osteoarthritis among them. Outside those thresholds you pay the full price: 146.91 € to 195.10 € a month for Wegovy and 176.10 € to 433.80 € for Mounjaro, by dose.

Reimbursement changes what a tracking app is for. When treatment is funded and followed, the follow-up appointment becomes the moment that matters - and turning up with a dated record of doses, side effects, and weight is worth more than a recollection. It is also why Shotsy’s PDF export deserves more weight in France than anywhere else on this list.

The follow-up consultation is now the pivot

Reimbursement comes with review. A funded course of treatment runs through your médecin traitant, and the renewal conversation turns on what actually happened between appointments: which doses you took, which weeks were bad, what the weight curve did. Arriving with a printout rather than a recollection is a small advantage that compounds over a year - and it is the reason a mid-table feature like an export earns disproportionate weight in the French context.

Privacy: the CNIL, GDPR, and health data

GLP-1 use is exactly the kind of data most people would rather not leave lying around, and French readers have the CNIL - one of Europe’s most active regulators on health data - standing behind their GDPR rights of access, portability, and erasure. Worth exercising before committing a year of treatment to any one app.

Phaze is the strictest: AES-256 on the device, no cloud storage, no analytics on medical data. GlucoPal asks for no account and backs up to your own iCloud rather than a vendor server. Zenday approaches the problem from another angle: its web version leaves no App Store trail and no icon on your phone screen. At the far end, MyFitnessPal carries a decade of advertising integrations and is the widest data surface on this list. None publishes an independent audit backing what it claims.

Not to be confused with télémédecine

A tracker assumes you already have an ordonnance; a telehealth platform writes one, supplies the medicine, and bills for it. Different rules, different incentives. Apps that edge toward a prescribing posture are capped at 1/5 on our Safety pillar no matter how strong the tracking is.

Related guides

The full list, with all ten apps scored pillar by pillar, is in our GLP-1 app ranking. If you also work with research peptides, our peptide app ranking uses exactly the same rubric, and for ordering into France there is our guide to where to buy peptides in France.

How we score

We use an anchored 1-5 rubric: Functionality (30%), Privacy (25%), Reliability (20%), UX (15%), Honest pricing (5%), and Safety content (5%) - applied identically to every app and fully auditable. We publish the weights before the results so you can redo the arithmetic yourself; the detail is on the methodology page. No paid placements, no developer promo codes, and no hidden arrangements: funded from our own budget, not by anyone on this list.